Influential Scientific Journal Rips Effort to Loosen Stem Cell Research Rules
The prestigious journal Nature today editorialized against easing federal regulation of stem cell treatments, a major blow to the campaign by the California stem cell agency to speed such therapies to the marketplace.
The headline on the piece said,
"FDA should stand firm on stem cell treatments."
The unsigned editorial declared that those who contend that…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.